Exploiting human memory B cell heterogeneity for improved vaccine efficacy

23Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.

Abstract

The major goal in vaccination is establishment of long-term, prophylactic humoral memory to a pathogen.Two major components to long-lived humoral memory are plasma cells for the production of specific immunoglobulin and memory B cells that survey for their specific antigen in the periphery for later affinity maturation, proliferation, and differentiation. The study of human B cell memory has been aided by the discovery of a general marker for B cell memory, expression of CD27; however, new data suggests the existence of CD27- memory B cells as well.These recently described non-canonical memory populations have increasingly pointed to the heterogeneity of the memory compartment. The novel B memory subsets in humans appear to have unique origins, localization, and functions compared to what was considered to be a "classical" memory B cell. In this article, we review the known B cell memory subsets, the establishment of B cell memory in vaccination and infection, and how understanding these newly described subsets can inform vaccine design and disease treatment. © 2011 Pauli, Henry Dunand and Wilson. This is an open-access.

Cite

CITATION STYLE

APA

Pauli, N. T., Henry Dunand, C. J., & Wilson, P. C. (2011). Exploiting human memory B cell heterogeneity for improved vaccine efficacy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2011.00077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free